The Scientist

» Saccharomyces

Most Recent

image: Yeast Genome Doubling

Yeast Genome Doubling

By | August 10, 2015

The results of a computational genetic analysis suggest Saccharomyces cerevisiae doubled its genome through species hybridization.

0 Comments

image: Modified Yeast Tolerate Alcohol, Heat

Modified Yeast Tolerate Alcohol, Heat

By | October 2, 2014

Simple changes help yeast thrive in the presence of their own harmful byproducts and could boost biofuel production.

0 Comments

image: Week in Review: November 4–8

Week in Review: November 4–8

By | November 8, 2013

Infant immune systems suppressed; why tissues are tough to freeze; silencing one gene causes secondary effects; estrogen’s role in drug-resistant breast cancer

0 Comments

image: One Gene, Two Mutations

One Gene, Two Mutations

By | November 5, 2013

Knocking down a single gene spurs pronounced secondary effects in the yeast genome.

6 Comments

image: A New Model of Yeast Aging

A New Model of Yeast Aging

By | November 23, 2011

New findings challenge long-held views about the mechanism yeast cells use to live forever.

6 Comments

image: Genome Digest

Genome Digest

By | June 28, 2011

Meet the species whose DNA has recently been sequenced.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham